ES8300321A1 - Un procedimiento para la preparacion de nuevas prostaglandi-nas - Google Patents

Un procedimiento para la preparacion de nuevas prostaglandi-nas

Info

Publication number
ES8300321A1
ES8300321A1 ES506097A ES506097A ES8300321A1 ES 8300321 A1 ES8300321 A1 ES 8300321A1 ES 506097 A ES506097 A ES 506097A ES 506097 A ES506097 A ES 506097A ES 8300321 A1 ES8300321 A1 ES 8300321A1
Authority
ES
Spain
Prior art keywords
formula
preparation
pharmaceutical compositions
reaction
prostaglandin derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES506097A
Other languages
English (en)
Other versions
ES506097A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES8300321A1 publication Critical patent/ES8300321A1/es
Publication of ES506097A0 publication Critical patent/ES506097A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE PROSTAGLANDINAS Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE R ES HIDROGENO O ALQUILO INFERIOR. CONSISTE EN LA REACCION DE ACETILACION DE UN COMPUESTO DE FORMULA (II), EN LA QUE R ES EL MISMO QUE EN LA FORMULA (I), CON UN AGENTE ACETILANTE CONVENCIONAL. LA REACCION SE LLEVA A CABO A UNA TEMPERATURA COMPRENDIDA ENTRE -10<025>C Y 50<025>C Y LA SEPARACION Y PURIFICACION DEL PRODUCTO OBTENIDO SE EFECTUA SIGUIENDO METODOS CONVENCIONALES. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS COMO INHIBIDORES DE LA SECRECION GASTRICA.
ES506097A 1980-10-09 1981-10-08 Un procedimiento para la preparacion de nuevas prostaglandi-nas Granted ES506097A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/195,576 US4325970A (en) 1980-10-09 1980-10-09 15-Acetyl-prostaglandins

Publications (2)

Publication Number Publication Date
ES8300321A1 true ES8300321A1 (es) 1982-11-01
ES506097A0 ES506097A0 (es) 1982-11-01

Family

ID=22721938

Family Applications (1)

Application Number Title Priority Date Filing Date
ES506097A Granted ES506097A0 (es) 1980-10-09 1981-10-08 Un procedimiento para la preparacion de nuevas prostaglandi-nas

Country Status (26)

Country Link
US (1) US4325970A (es)
EP (1) EP0049853B1 (es)
JP (1) JPS5793956A (es)
KR (1) KR880000892B1 (es)
AR (1) AR228758A1 (es)
AT (1) ATE11772T1 (es)
AU (1) AU548782B2 (es)
BR (1) BR8106518A (es)
CA (1) CA1222512A (es)
CS (1) CS221993B2 (es)
CU (1) CU35543A1 (es)
DE (1) DE3168920D1 (es)
DK (1) DK442981A (es)
ES (1) ES506097A0 (es)
FI (1) FI70884C (es)
GR (1) GR75074B (es)
HU (1) HU187376B (es)
IE (1) IE51638B1 (es)
IL (1) IL63962A (es)
MC (1) MC1425A1 (es)
NO (1) NO813411L (es)
NZ (1) NZ198521A (es)
PH (1) PH16418A (es)
PT (1) PT73793B (es)
ZA (1) ZA816202B (es)
ZW (1) ZW21881A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0597095B1 (en) * 1991-04-22 1996-10-30 Taisho Pharmaceutical Co. Ltd Prostaglandin e1 analogue
IL160166A0 (en) * 2001-09-10 2004-07-25 Tibotec Pharm Ltd Method for the preparation of hexahydro-furo[2,3-b] furan-3-ol
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1440361A (en) * 1972-07-24 1976-06-23 American Cyanamid Co 11-deoxyprostaglandins of the e and f series and the preparation thereof
US4141914A (en) * 1972-07-24 1979-02-27 American Cyanamid Company Novel 11-deoxy-11-substituted prostaglandins of the E and F series
US4052446A (en) * 1973-08-06 1977-10-04 Hoffmann-La Roche Inc. 11,16-substituted prostaglandins

Also Published As

Publication number Publication date
JPH039105B2 (es) 1991-02-07
HU187376B (en) 1985-12-28
NO813411L (no) 1982-04-13
ATE11772T1 (de) 1985-02-15
PT73793A (en) 1981-11-01
IE812355L (en) 1982-04-09
PT73793B (en) 1983-10-31
IE51638B1 (en) 1987-01-21
KR830007545A (ko) 1983-10-21
DK442981A (da) 1982-04-10
EP0049853A1 (de) 1982-04-21
ZA816202B (en) 1982-09-29
DE3168920D1 (en) 1985-03-28
AU548782B2 (en) 1986-01-02
FI70884C (fi) 1986-10-27
CU35543A1 (es) 1983-05-05
MC1425A1 (fr) 1982-10-18
FI813140L (fi) 1982-04-10
CS221993B2 (en) 1983-04-29
ES506097A0 (es) 1982-11-01
NZ198521A (en) 1984-04-27
PH16418A (en) 1983-09-29
BR8106518A (pt) 1982-06-29
ZW21881A1 (en) 1982-05-05
IL63962A (en) 1985-05-31
AU7602481A (en) 1982-04-22
US4325970A (en) 1982-04-20
CA1222512A (en) 1987-06-02
GR75074B (es) 1984-07-13
IL63962A0 (en) 1981-12-31
EP0049853B1 (de) 1985-02-13
JPS5793956A (en) 1982-06-11
KR880000892B1 (ko) 1988-05-30
AR228758A1 (es) 1983-04-15
FI70884B (fi) 1986-07-18

Similar Documents

Publication Publication Date Title
US4115454A (en) 2-Decarboxy-2-hydroxy-methyl-5-oxa-ω-phenyl-pgd1 compounds
ES8203076A1 (es) Procedimiento para preparar derivados de guanidina.
ES8301961A1 (es) Procedimiento para la preparacion de nuevos benzo (b) tiofe-nos
FR2360561A1 (fr) Nouveaux dipeptides utiles comme inhibiteurs de l&#39;elastase
GB1459564A (en) Alkylphenyl benzopyrans
FR2395269A1 (fr) Procede de preparation de 7,8-dihydro-14-hydroxynormorphinone
FR2361346A1 (fr) Dipeptides utiles comme medicaments
ES8300321A1 (es) Un procedimiento para la preparacion de nuevas prostaglandi-nas
ES8106289A1 (es) Procedimiento de preparacion de nuevos derivados del a-fe- nil-2-pirrolidin-metanol
ES421067A1 (es) Procedimiento para la preparacion de nuevas 2-fenilamino- imidazolinas sustituidas.
ES463784A1 (es) Un procedimiento para la preparacion de un compuesto cis.
NZ189091A (en) Prostaglandin derivatives
ES452772A1 (es) Un procedimiento para la produccion de un dibenzo (b-d)-pi- rano.
US4208538A (en) 2-Decarboxy-2-hydroxymethyl-3,7-inter-m-phenylene-ω-phenyl-PGF2 compounds
ES8405797A1 (es) Procedimiento de preparacion de nuevos derivados del azabiciclo (3.2.0) heptano.
IE42966L (en) 8-azaprostaglandins and process for the preparation thereof.
ES363875A1 (es) Procedimiento para la obtencion de compuestos heterocicli- cos.
IL57971A (en) Prostaglandin derivatives of the delta2-pge2 and delta2-pgf2 series,process for their manufacture and pharmaceutical compositions containing them
ES476405A1 (es) Un metodo para la preparacion de 2-metiltio-6-fluoro-9-(1- metil-4-piperilideno)-tioxanteno
IE43453L (en) 15-(1,3-benzodioxan-2-yl)-16,17,19,20-pentanor prostanoic¹acid derivatives
JPS5265251A (en) Synthesis of prostaglandin derivatives
ES8107184A1 (es) Procedimiento para preparar 1-ciclohexenilmetil-2-cloroetil-pirrolidina
JPS5283346A (en) Synthesis of 4-n-alkoxy-alpha-methylcinnamic acid-4&#39;-cyanophenyl ester
JPS5271478A (en) Synthesis of novel derivatives of kanamycin b
ES8102571A1 (es) Un procedimiento para la preparacion de derivados de oxadia-zolotriazona